Introducing Spigen's Premier "Made for Google" Cases Tailored for the Pixel 8A
IRVINE, Calif., May 7, 2024 /PRNewswire/ -- Spigen announces a new line-up for Pixel 8A, highlighting durability, sleek designs, and a variety of "Made for Google" cases.
Spigen's newest "Made for Google" cases for the Pixel 8A have been designed and certified to meet Google's compatibility standards. From minimalist to tough cases, Spigen offers a diverse range of products suitable for anyone, ensuring there's something to match every style and preference. Whether you're seeking a barely-there case or in need of heavy-duty protection, Spigen has you covered.
Introducing the captivating Ultra Hybrid ZeroOne case for Pixel 8a, boasting features like an innovative tear-down design that's sure to turn heads with its unique yet elegant aesthetic. Look out for the release next week.
Alternatively, the Rugged Armor case has quickly become a fan favorite, providing overall protection while maintaining a slim and sleek design enhanced by its carbon fiber pattern. It's the go-to choice that keeps people coming back for its perfect balance of durability and style.
For those seeking sophistication alongside protection, look no further than Liquid Air. Crafted with a unique textured design, this case offers a thin yet reliable shield with an enhanced grip for your Pixel 8A.
The Pixel 8A "Made for Google" lineup and collection can be found on Amazon.
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024).
The campaign focuses on access to IBD care and treatment as the burden of...
The global industrial automation market in life sciences industry size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.4% during the forecast period. ...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...